Two Sigma Advisers’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-26,037
Closed -$172K 2539
2019
Q1
$172K Buy
26,037
+1,129
+5% +$7.44K ﹤0.01% 2140
2018
Q4
$178K Buy
24,908
+11,030
+79% +$123K ﹤0.01% 2153
2018
Q3
$265K Buy
13,878
+8,140
+142% +$290K ﹤0.01% 1997
2018
Q2
$325K Buy
+5,738
New +$291K ﹤0.01% 2074
2017
Q4
Sell
-1,690
Closed -$75K 2451
2017
Q3
$75K Buy
+1,690
New +$77K ﹤0.01% 2134
2017
Q1
Sell
-9,348
Closed -$535K 2533
2016
Q4
$535K Buy
+9,348
New +$856K ﹤0.01% 1844
2016
Q3
Sell
-2,750
Closed -$343K 2372
2016
Q2
$343K Sell
2,750
-1,100
-29% -$126K ﹤0.01% 1666
2016
Q1
$322K Buy
+3,850
New +$317K ﹤0.01% 1638
2015
Q3
Sell
-1,655
Closed -$254K 2082
2015
Q2
$254K Buy
+1,655
New +$273K ﹤0.01% 1679
2014
Q1
Sell
-6,945
Closed -$1.21M 2650
2013
Q4
$1.21M Buy
6,945
+3,880
+127% +$667K 0.01% 1034
2013
Q3
$495K Buy
+3,065
New +$483K 0.01% 1388

Other funds holding ELGX

Two Sigma Advisers's ELGX Position: Q2 2019 in Review

Two Sigma Advisers sold out of Endologix Inc (ELGX) in Q2 2019, closing a stake of 26,037 shares — an estimated $172K sold.

Two Sigma Advisers first reported a position in ELGX in Q3 2013 and held it in 11 quarters. The position peaked at $1.21M in Q4 2013. 75 funds tracked by Wall St. Rank hold ELGX as of Q2 2019.

  • Two Sigma Advisers reported no remaining Endologix Inc position as of Q2 2019 after selling out during the quarter.
  • Two Sigma Advisers sold 26,037 Endologix Inc shares in Q2 2019, an estimated $172K.
  • Two Sigma Advisers first reported a position in Endologix Inc in Q3 2013 and held it in 11 quarters.
  • Two Sigma Advisers's Endologix Inc position peaked at $1.21M in Q4 2013.
  • 75 funds tracked by Wall St. Rank held Endologix Inc as of Q2 2019.

Based on Two Sigma Advisers's 13F filing for Q2 2019, filed 14 Aug 2019.